Global Dendritic Cell Cancer Vaccine Market Report 2016-2020 - Trends, Technologies & Opportunities - Key Vendors: Activartis, Batavia Bioservices, DanDrit Biotech

Mar 03, 2016, 07:10 ET from Research and Markets

DUBLIN, March 3, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/8s8p7d/global_dendritic) has announced the addition of the "Global Dendritic Cell Cancer Vaccine Market Outlook 2020" report to their offering.

There are several combinational therapies wherein dendritic cells are administered along with monoclonal antibodies, antibody-drug conjugates and peptide based vaccines to increase the efficacy of the vaccines. This is because of the fact that in the cancer patients, the immune system is already compromised, besides the tumor microenvironment which negates the mechanism of action of immunological cells. The role of conventional therapy like chemotherapy, surgical removal of tumor cells or radiotherapy also needs to be underscored as they help in reducing the bulk of tumorous growth. The cancer based vaccines when administered thereafter, is reported to have increased efficiency.

As dendritic cells are found to have a modulatory effect on almost all the parameters of the immune system, all other types of cancer vaccines are found to be administered in conjugation with dendritic cells cancer vaccine to have a synergistic effect on immune system against tumor growth. With further advancement in immunological studies, dendritic cells cancer vaccine will have a driving effect on cancer therapeutics which will have a lion's share on cancer vaccine market.

Key Topics Covered:

  • Introduction & Mechanism of Action of Dendritic Cells
  • New Vaccine Strategies That Exploit Dendritic Cells Biochemistry
  • Dendritic Cell Cancer Vaccine Market & Clinical Insight
  • Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines
  • Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase
  • Dendritic Cell Cancer Vaccine Clinical Pipeline: 58 Vaccines

Companies Mentioned:

  • 3M Company
  • Activartis
  • Argos Therapeutics
  • Batavia Bioservices
  • Bellicum Pharmaceuticals
  • Creagene
  • DanDrit Biotech
  • DCPrime
  • Dendreon Corporation
  • Elios Therapeutics
  • ImmunoCellular Therapeutics
  • Immunicum
  • Kiromic
  • Medigene
  • Merck
  • Northwest Biotherapeutics
  • Glaxo Smith Kline
  • ImmunoCellular Therapeutics
  • SOTIO
  • Tella Incorporation
  • Theravectys
  • Vaxil BioTherapeutics

Report Structure:

1. Dendritic Cells Cancer Vaccine: The Genesis

2. Classification of Dendritic Cells

3. Mechanism of Action of Dendritic Cells

4. New Vaccine Strategies That Exploit Dendritic Cells Biochemistry

5. Dendritic Cell Cancer Vaccine Market & Clinical Insight

6. A Comparative Insight of Dendritic Cell Vaccines & its Peers

7. The Growth Factors: Why the Fixation with Dendritic Cell Cancer Vaccines?

8. Road Ahead: Dendritic Cell Cancer Vaccine in the Challenging Horizon of Cancer Immunotherapy

9. Conclusion: Dendritic Cell Cancer Vaccine; a Silver Lining to the Dark Under-Belly of Cancer

10. Dendritic Cell Cancer Vaccine Clinical Pipeline By Country, Company, Indication & Phase

11. Marketed Dendritic Cell Cancer Vaccine: CreaVax® ( Renal Cancer, South Korea)

12. Market Withdrawl: Provenge by Dendreon Corporation

13. Discontinued & Suspended Dendritic Cell Cancer Vaccine in Clinical Trials

14. Competitve Landscape

For more information visit http://www.researchandmarkets.com/research/8s8p7d/global_dendritic

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com